annual CFO:
-$520.73M+$6.99M(+1.33%)Summary
- As of today (May 29, 2025), BBIO annual cash flow from operations is -$520.73 million, with the most recent change of +$6.99 million (+1.33%) on December 31, 2024.
- During the last 3 years, BBIO annual CFO has fallen by -$22.79 million (-4.58%).
- BBIO annual CFO is now -1186.12% below its all-time high of -$40.49 million, reached on December 31, 2017.
Performance
BBIO Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$199.24M-$3.91M(-2.00%)Summary
- As of today (May 29, 2025), BBIO quarterly cash flow from operations is -$199.24 million, with the most recent change of -$3.91 million (-2.00%) on March 31, 2025.
- Over the past year, BBIO quarterly CFO has increased by +$20.30 million (+9.25%).
- BBIO quarterly CFO is now -366.70% below its all-time high of $74.70 million, reached on June 30, 2024.
Performance
BBIO quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$500.42M+$20.30M(+3.90%)Summary
- As of today (May 29, 2025), BBIO TTM cash flow from operations is -$500.42 million, with the most recent change of +$20.30 million (+3.90%) on March 31, 2025.
- Over the past year, BBIO TTM CFO has increased by +$102.51 million (+17.00%).
- BBIO TTM CFO is now -2687.72% below its all-time high of -$17.95 million, reached on March 31, 2018.
Performance
BBIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BBIO Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.3% | +9.3% | +17.0% |
| 3 y3 years | -4.6% | -24.0% | +1.4% |
| 5 y5 years | -105.3% | -137.4% | -79.8% |
BBIO Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.1% | +1.3% | -366.7% | +9.3% | -24.1% | +17.0% |
| 5 y | 5-year | -105.3% | +1.3% | -366.7% | +9.3% | -79.8% | +17.0% |
| alltime | all time | -1186.1% | +1.3% | -366.7% | +9.3% | -2687.7% | +17.0% |
BBIO Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$199.24M(+2.0%) | -$500.42M(-3.9%) |
| Dec 2024 | -$520.73M(-1.3%) | -$195.33M(+8.2%) | -$520.73M(+15.7%) |
| Sep 2024 | - | -$180.57M(-341.7%) | -$450.22M(+8.5%) |
| Jun 2024 | - | $74.70M(-134.0%) | -$414.88M(-31.2%) |
| Mar 2024 | - | -$219.54M(+75.9%) | -$602.93M(+14.3%) |
| Dec 2023 | -$527.72M(+25.8%) | -$124.82M(-14.1%) | -$527.72M(+6.4%) |
| Sep 2023 | - | -$145.23M(+28.1%) | -$496.14M(+2.1%) |
| Jun 2023 | - | -$113.35M(-21.5%) | -$486.08M(+20.6%) |
| Mar 2023 | - | -$144.32M(+54.8%) | -$403.18M(-3.9%) |
| Dec 2022 | -$419.49M(-15.8%) | -$93.24M(-31.0%) | -$419.49M(-8.8%) |
| Sep 2022 | - | -$135.16M(+343.8%) | -$460.15M(+3.0%) |
| Jun 2022 | - | -$30.45M(-81.0%) | -$446.54M(-12.1%) |
| Mar 2022 | - | -$160.63M(+20.0%) | -$507.80M(+2.0%) |
| Dec 2021 | -$497.93M | -$133.90M(+10.1%) | -$497.93M(+8.2%) |
| Sep 2021 | - | -$121.56M(+32.5%) | -$460.30M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$91.71M(-39.2%) | -$470.42M(+0.8%) |
| Mar 2021 | - | -$150.76M(+56.6%) | -$466.56M(+16.7%) |
| Dec 2020 | -$399.71M(+57.6%) | -$96.26M(-26.9%) | -$399.71M(+5.3%) |
| Sep 2020 | - | -$131.68M(+49.9%) | -$379.66M(+27.4%) |
| Jun 2020 | - | -$87.85M(+4.7%) | -$297.97M(+7.0%) |
| Mar 2020 | - | -$83.92M(+10.1%) | -$278.37M(+9.8%) |
| Dec 2019 | -$253.59M(+85.6%) | -$76.20M(+52.4%) | -$253.59M(+13.3%) |
| Sep 2019 | - | -$50.00M(-26.7%) | -$223.80M(+5.5%) |
| Jun 2019 | - | -$68.25M(+15.4%) | -$212.12M(+19.3%) |
| Mar 2019 | - | -$59.14M(+27.4%) | -$177.83M(+30.1%) |
| Dec 2018 | -$136.64M(+237.5%) | -$46.41M(+21.1%) | -$136.64M(+51.4%) |
| Sep 2018 | - | -$38.32M(+12.9%) | -$90.23M(+73.8%) |
| Jun 2018 | - | -$33.96M(+89.2%) | -$51.91M(+189.2%) |
| Mar 2018 | - | -$17.95M | -$17.95M |
| Dec 2017 | -$40.49M | - | - |
FAQ
- What is BridgeBio Pharma annual cash flow from operations?
- What is the all time high annual CFO for BridgeBio Pharma?
- What is BridgeBio Pharma annual CFO year-on-year change?
- What is BridgeBio Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly CFO year-on-year change?
- What is BridgeBio Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for BridgeBio Pharma?
- What is BridgeBio Pharma TTM CFO year-on-year change?
What is BridgeBio Pharma annual cash flow from operations?
The current annual CFO of BBIO is -$520.73M
What is the all time high annual CFO for BridgeBio Pharma?
BridgeBio Pharma all-time high annual cash flow from operations is -$40.49M
What is BridgeBio Pharma annual CFO year-on-year change?
Over the past year, BBIO annual cash flow from operations has changed by +$6.99M (+1.33%)
What is BridgeBio Pharma quarterly cash flow from operations?
The current quarterly CFO of BBIO is -$199.24M
What is the all time high quarterly CFO for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly cash flow from operations is $74.70M
What is BridgeBio Pharma quarterly CFO year-on-year change?
Over the past year, BBIO quarterly cash flow from operations has changed by +$20.30M (+9.25%)
What is BridgeBio Pharma TTM cash flow from operations?
The current TTM CFO of BBIO is -$500.42M
What is the all time high TTM CFO for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM cash flow from operations is -$17.95M
What is BridgeBio Pharma TTM CFO year-on-year change?
Over the past year, BBIO TTM cash flow from operations has changed by +$102.51M (+17.00%)